参考文献/References:
[1] Zhang L,Wang Z,Wang X,et al. Prevalence of Abdominal Obesity in China: Results from a Cross-Sectional Study of Nearly Half a Million Participants[J]. Obesity (Silver Spring),2019,27(11):1898-1905.
[2] Koliaki C,Liatis S,Kokkinos A. Obesity and cardiovascular disease:revisiting an old relationship[J]. Metabolism,2019,92:98-107.
[3] Wharton S,Lau DCW,Vallis M,et al. Obesity in adults:a clinical practice guideline[J]. Cmaj,2020,192(31):E875-E891.
[4] Piché ME,Poirier P,Lemieux I,et al. Overview of epidemiology and contribution of obesity and body fat distribution to cardiovascular disease:an update[J]. Prog Cardiovasc Dis,2018,61(2):103-113.
[5] Sahakyan KR,Somers VK,Rodriguez-Escudero JP,et al. Normal-weight central obesity:implications for total and cardiovascular mortality[J]. Ann Intern Med,2015,163(11):827-835.
[6] Fox CS,Massaro JM,Hoffmann U,et al. Abdominal visceral and subcutaneous adipose tissue compartments:association with metabolic risk factors in the Framingham Heart Study[J]. Circulation,2007,116(1):39-48.
[7] Koh H,Hayashi T,Sato KK,et al. Visceral adiposity,not abdominal subcutaneous fat area,is associated with high blood pressure in Japanese men:the Ohtori study[J]. Hypertens Res,2011,34(5):565-572.
[8] Chandra A,Neeland IJ,Berry JD,et al. The relationship of body mass and fat distribution with incident hypertension:observations from the Dallas Heart Study[J]. J Am Coll Cardiol,2014,64(10):997-1002.
[9] Amato MC,Giordano C,Galia M,et al. Visceral adiposity index:a reliable indicator of visceral fat function associated with cardiometabolic risk[J]. Diabetes Care,2010,33(4):920-922.
[10] Bozorgmanesh M,Hadaegh F,Azizi F. Predictive performances of lipid accumulation product vs. adiposity measures for cardiovascular diseases and all-cause mortality,8.6-year follow-up:Tehran lipid and glucose study[J]. Lipids Health Dis,2010,9:100.
[11] Xia MF,Chen Y,Lin HD,et al. A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese[J]. Sci Rep,2016,6:38214.
[12] Leite NN,Cota BC,Gotine AREM,et al. Visceral adiposity index is positively associated with blood pressure:A systematic review[J]. Obes Res Clin Pract,2021,15(6):546-556.
[13] Fiorentino TV. Visceral adiposity index (VAI),a powerful predictor of incident hypertension in prehypertensives[J]. Intern Emerg Med,2018,13(4):471-473.
[14] Cheng C,Yu X,Shi K,et al. Associations between abdominal obesity indices with hypertension in type 2 diabetes mellitus:Chinese visceral adiposity index[J]. J Endocrinol Invest,2024,47(3):547-555.
[15] Gui J,Li Y,Liu H,et al. Obesity-and lipid-related indices as a risk factor of hypertension in mid-aged and elderly Chinese:A cross-sectional study[J]. BMC Geriatr,2024,24(1):77.
[16] 陈奕钿,蔺有林,李泽亚,等. 社区不同性别老年人的中国人内脏脂肪指数与高血压风险的关联[J]. 中华高血压杂志(中英文),2024,32(10):978-984.
[17] Niu ZJ,Cui Y,Wei T,et al. The effect of insulin resistance in the association between obesity and hypertension incidence among Chinese middle-aged and older adults:data from China health and retirement longitudinal study (CHARLS)[J]. Front Public Health,2024,12:1320918.
[18] Jung JY,Oh CM,Jo HC,et al. Predictive ability of the Chinese visceral adiposity index for incident hypertension in working-aged Koreans[J]. Epidemiol Health,2024,46:e2024034.
[19] Vasan RS,Larson MG,Leip EP,et al. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study:a cohort study[J]. Lancet,2001,358(9294):1682-1686.
[20] Hu L,Huang X,You C,et al. Prevalence and Risk Factors of Prehypertension and Hypertension in Southern China[J]. PLoS One,2017,12(1):e0170238.
[21] Li B,Wang J,Zhou X,et al. Chinese visceral adiposity index is more closely associated with hypertension and prehypertension than traditional adiposity indices in Chinese Population:Results From the REACTION Study[J]. Front Endocrinol (Lausanne),2022,13:921997.
[22] Lombardo M,Feraco A,Bellia C,et al. Influence of nutritional status and physical exercise on immune response in metabolic syndrome[J]. Nutrients,2022,14(10):2054.
[23] Gast KB,den Heijer M,Smit JW,et al. Individual contributions of visceral fat and total body fat to subclinical atherosclerosis:The NEO study[J]. Atherosclerosis,2015,241(2):547-554.
[24] Liu L,Peng J,Wang N,et al. Comparison of seven surrogate insulin resistance indexes for prediction of incident coronary heart disease risk:a 10-year prospective cohort study[J]. Front Endocrinol (Lausanne),2024,15:1290226.
[25] Xie Y,Zhang Y,Qin P,et al. The association between Chinese Visceral Adipose Index and coronary heart disease:A cohort study in China[J]. Nutr Metab Cardiovasc Dis,2022,32(3):550-559.
[26] Gordon DJ,Probstfield JL,Garrison RJ,et al. High-density lipoprotein cholesterol and cardiovascular disease.Four prospective American studies[J]. Circulation,1989,79(1):8-15.
[27] Soubassi LP,Chiras TC,Papadakis ED,et al. Incidence and risk factors of coronary heart disease in elderly patients on chronic hemodialysis[J]. Int Urol Nephrol,2006,38(3-4):795-800.
[28] Wilson PW,D’Agostino RB,Levy D,et al. Prediction of coronary heart disease using risk factor categories[J]. Circulation,1998,97(18):1837-1847.
[29] Liu L,Peng J,Zang D,et al. The Chinese visceral adiposity index:a novel indicator more closely related to cardiovascular disease than other abdominal obesity indices among postmenopausal women[J]. J Transl Med,2024,22(1):855.
[30] Cai X,Li N,Hu J,et al. Nonlinear relationship between Chinese visceral adiposity index and new-onset myocardial infarction in patients with hypertension and obstructive sleep apnoea:insights from a cohort study[J]. J Inflamm Res,2022,15:687-700.
[31] Qiao T,Luo T,Pei H,et al. Association between abdominal obesity indices and risk of cardiovascular events in Chinese populations with type 2 diabetes:a prospective cohort study[J]. Cardiovasc Diabetol,2022,21(1):225.
[32] Xie H,Li J,Zhu X,et al. Association between healthy lifestyle and the occurrence of cardiometabolic multimorbidity in hypertensive patients:a prospective cohort study of UK Biobank[J]. Cardiovasc Diabetol,2022,21(1):199.
[33] Neeland IJ,Ross R,Després JP,et al. Visceral and ectopic fat, atherosclerosis,and cardiometabolic disease:a position statement[J]. Lancet Diabetes Endocrinol,2019,7(9):715-725.
[34] Dong T,Lin W,Zhou Q,et al. Association of adiposity indicators with cardiometabolic multimorbidity risk in hypertensive patients:a large cross-sectional study[J]. Front Endocrinol (Lausanne),2024,15:1302296.
[35] Xiao D,Sun H,Chen L,et al. Assessment of six surrogate insulin resistance indexes for predicting cardiometabolic multimorbidity incidence in Chinese middle-aged and older populations:Insights from the China health and retirement longitudinal study[J]. Diabetes Metab Res Rev,2024,40(1):e3764.
[36] Ye X,Zhang G,Han C,et al. The association between Chinese visceral adiposity index and cardiometabolic multimorbidity among Chinese middle-aged and older adults:a national cohort study[J]. Front Endocrinol (Lausanne),2024,15:1381949.
[37] Falk E. Pathogenesis of atherosclerosis[J]. J Am Coll Cardiol,2006,47(8 Suppl):C7-C12.
[38] Wang X,Si Z,Wang H,et al. Association of Chinese visceral adiposity index and carotid atherosclerosis in steelworkers:a cross-sectional study[J]. Nutrients,2023,15(4):1023.
[39] Liu Z,Deng B,Huang Q,et al. Comparison of seven surrogate insulin resistance indexes for predicting the prevalence of carotid atherosclerosis in normal-weight individuals[J]. Front Public Health,2023,11:1241523.
[40] Li B,Lai X,Yan C,et al. The associations between neutrophil-to-lymphocyte ratio and the Chinese Visceral Adiposity Index, and carotid atherosclerosis and atherosclerotic cardiovascular disease risk[J]. Exp Gerontol,2020,139:111019.
相似文献/References:
[1]白春兰,张军.正五聚蛋白-3:新型心血管病炎性标志物[J].心血管病学进展,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
BAI Chunlan,ZHANG Jun.Pentraxin-3: A Novel Inflammation Biomarker for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(7):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
[2]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(7):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[3]尹琳 黄从新.JP2蛋白和心血管疾病的研究进展[J].心血管病学进展,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
YIN Lin HUANG Congxin.Research Progress of JP2 Protein and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
[4]朱峰 汪汉 蔡琳.抗体与心血管疾病[J].心血管病学进展,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
ZHU FengWANG HanCAI Lin.Antibodies and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
[5]邱明仙 王正龙 许官学.心肌肌球蛋白结合蛋白-C磷酸化与心血管疾病关系的研究进展[J].心血管病学进展,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
QIU MingxianWANG ZhenglongXU Guanxue.Research Progress of the Relationship Between Cardiac Myosin Binding Protein-C and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
[6]姬楠楠 杨晓静 谢勇.单核细胞/高密度脂蛋白比值与心血管疾病的研究进展[J].心血管病学进展,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
JI Nannan YANG Xiaojing XIE Yong.Monocyte/High-density Lipoprotein Ratio and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
[7]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]
[8]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(7):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[9]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(7):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
[10]韦莹 刘书旺 李蕾 崔鸣.生长分化因子-15在心房颤动中的研究进展[J].心血管病学进展,2019,(8):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]
WEI Ying,LIU Shuwang,LI Lei,et al.Growth Differentiation Factor-15 in Development of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(7):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]